In the News

Research advances from the National Institutes of Health (NIH) Intramural Research Program (IRP) often make headlines. Read the news releases that describe our most recent findings:

Featured Article

Here’s when your weight loss will plateau, according to science

CNN
Monday, April 22, 2024

Whether you’re shedding pounds with the help of effective new medicines, slimming down after weight loss surgery or cutting calories and adding exercise, there will come a day when the numbers on the scale stop going down, and you hit the dreaded weight loss plateau.

In a recent study, Kevin Hall, a researcher at the National Institutes of Health who specializes in measuring metabolism and weight change, looked at when weight loss typically stops depending on the method people were using to drop pounds. He broke down the plateau into mathematical models using data from high-quality clinical trials of different ways to lose weight to understand why people stop losing when they do. The study published Monday in the journal Obesity.

Study identifies African-specific genomic variant associated with obesity

Findings highlight the importance of genomic studies in diverse populations.

An international team of researchers has conducted the first study of its kind to look at the genomic underpinnings of obesity in continental Africans and African-Americans. They discovered that approximately 1 percent of West Africans, African-Americans and others of African ancestry carry a genomic variant that increases their risk of obesity, a finding that provides insight into why obesity clusters in families. Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, and their African collaborators published their findings March 13, 2017, in the journal Obesity.

A healthcare provider examines a patient.

Extreme temperatures may increase risk for low birth weight at term, NIH study suggests

Extreme hot or cold temperatures during pregnancy may increase the risk that infants born at term will be of low birth weight, according to a study of U.S. women by researchers at the National Institutes of Health. The study was published in Environmental Research.

The authors found that exposure to atypically cold temperature during the entire pregnancy, or just during the second trimester and third trimester, increased the risk for low birth weight. Exposure to atypically hot temperatures during the whole pregnancy, or during the third trimester, also increased this risk. The odds for low term birth weight were highest when the whole pregnancy was exposed to extreme temperatures.

Respiratory syncytial virus vaccine enters clinical testing

NIH-led trial to evaluate RSV vaccine’s safety in healthy adults.

A Phase 1 clinical trial to test the safety and tolerability of an investigational vaccine against respiratory syncytial virus (RSV) has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial also will assess the vaccine’s ability to prompt an immune response in healthy adult participants. The investigational vaccine was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH.

NIH begins study of vaccine to protect against mosquito-borne diseases

Experimental vaccine targets mosquito saliva.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections. The study, which is being conducted at the NIH Clinical Center in Bethesda, Maryland, will examine the experimental vaccine’s safety and ability to generate an immune response.

NIH begins study of vaccine to protect against mosquito-borne diseases

Investigational PfSPZ malaria vaccine demonstrates considerable protection in Malian adults for duration of malaria season

An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria — the deadliest form of the disease — for the duration of the malaria season, according to new findings published in the February 15th issue of the journal Lancet Infectious Diseases. The study participants live in Mali, Africa, where they are naturally exposed to the parasite.

Investigational PfSPZ malaria vaccine demonstrates considerable protection in Malian adults for duration of malaria season

International study suggests Nodding syndrome caused by response to parasitic protein

NIH-funded study also identifies potential new mechanism for some forms of epilepsy.

Researchers at the National Institutes of Health have uncovered new clues to the link between Nodding syndrome, a devastating form of pediatric epilepsy found in specific areas of east Africa, and a parasitic worm that can cause river blindness. The study, published in Science Translational Medicine, suggests that the mysterious neurological disease may be caused by an autoimmune response to the parasitic proteins.

International study suggests Nodding syndrome caused by response to parasitic protein

Hair analysis may help diagnose Cushing Syndrome, NIH researchers report

Small study suggests that high cortisol level in hair may foretell hard-to-diagnose disorder.

Analyzing a hair sample may help with the diagnosis of Cushing Syndrome, a rare and potentially fatal disorder in which the body overproduces the stress hormone cortisol, according to researchers at the National Institutes of Health.

Diagnosing Cushing Syndrome is often difficult and time-consuming, requiring 24 hours to analyze blood and urine tests, brain imaging tests, and tissue samples from sinuses at the base of the skull. The researchers found that measuring cortisol levels in hair samples tracked closely with standard techniques for diagnosing Cushing Syndrome.

Aspirin may help prevent pregnancy loss in women with high inflammation, NIH study finds

A daily low dose of aspirin may help a subgroup of women, those who have previously lost a pregnancy, to successfully conceive and carry a pregnancy to term, according to an analysis by researchers at the National Institutes of Health. The women who benefited from the aspirin treatment had high levels of C-reactive protein (CRP), a substance in the blood indicating system-wide inflammation, which aspirin is thought to counteract. The study appears in the Journal of Clinical Endocrinology and Metabolism.

Couples with obesity may take longer to achieve pregnancy, NIH study suggests

Couples in which both partners are obese may take from 55 to 59 percent longer to achieve pregnancy, compared to their normal weight counterparts, according to a study by researchers at the National Institutes of Health. The findings appear online in Human Reproduction.

“A lot of studies on fertility and body composition have focused on the female partner, but our findings underscore the importance of including both partners,” said Rajeshwari Sundaram, Ph.D., a senior investigator in the Division of Intramural Population Health Research at NIH’s Eunice Kennedy ShriverNational Institute of Child Health and Human Development. “Our results also indicate that fertility specialists may want to consider couples’ body compositions when counseling patients.”

Continue Exploring the IRP

This page was last updated on Monday, April 22, 2024